Forbion Growth Opportunities Fund I Cooperatief U.A. insider trades: NewAmsterdam Pharma (NAMS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Forbion Growth Opportunities Fund I Cooperatief U.A. reports to the SEC
Open-market buys and sales
11 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | NAMS | ↓ Sell | 29,846 | $25.54 | $762K | Indirect | Jan 2, 2025 (3d) |
| Dec 27, 2024 | NAMS | ↓ Sell | 74,910 | $25.98 | $1.9M | Indirect | Dec 30, 2024 (3d) |
| Dec 24, 2024 | NAMS | ↓ Sell | 91,068 | $25.58 | $2.3M | Indirect | Dec 26, 2024 (2d) |
| Dec 19, 2024 | NAMS | ↓ Sell | 157,234 | $25.86 | $4.1M | Indirect | Dec 20, 2024 (1d) |
| Dec 17, 2024 | NAMS | ↓ Sell | 115,480 | $25.95 | $3.0M | Indirect | Dec 18, 2024 (1d) |
| Dec 13, 2024 | NAMS | ↓ Sell | 191,762 | $25.34 | $4.9M | Indirect | Dec 16, 2024 (3d) |
| Dec 11, 2024 | NAMS | ↓ Sell | 462,288 | $25.40 | $11.7M | Indirect | Dec 12, 2024 (1d) |
| Nov 18, 2024 | NAMS | ↓ Sell | 41,803 | $25.07 | $1.0M | Indirect | Nov 19, 2024 (1d) |
| Nov 14, 2024 | NAMS | ↓ Sell | 10,898 | $25.01 | $273K | Indirect | Nov 15, 2024 (1d) |
| Oct 30, 2024 | ENGN | ↑ Buy | 561,797 | $8.90 | $5.0M | Direct | Nov 1, 2024 (2d) |
| Oct 8, 2024 | ENGN | ↑ Buy | 470,633 | $6.40 | $3.0M | Direct | Oct 18, 2024 (10d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NAMS insiders
Open-market trades in the last 12 months
About Forbion Growth Opportunities Fund I Cooperatief U.A.'s insider trades
Forbion Growth Opportunities Fund I Cooperatief U.A. is an insider at NewAmsterdam Pharma (NAMS). Since Oct 8, 2024, it has reported 2 open-market purchases worth $8.0M and 9 sales worth $30.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (1 filing), shares returned to the company (1 filing), grants and awards (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NAMS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.